Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT04628338
What this trial is testing

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesMyeloid LeukemiaAllogeneic Stem Cell Transplantation
Sawa Ito, MD 8
Testing effectiveness (Phase 2)Ended earlyNCT02322190
What this trial is testing

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Who this might be right for
Chronic Graft vs. Host DiseaseGraft vs Host DiseaseGraft-Versus-Host Disease
National Cancer Institute (NCI) 5
Early research (Phase 1)WithdrawnNCT05443464
What this trial is testing

Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

Who this might be right for
GVHD,Acute
Ossium Health, Inc.
Large-scale testing (Phase 3)Ended earlyNCT04095858
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)

Who this might be right for
Hematopoietic Stem Cell TransplantationAcute Graft Versus Host DiseaseAcute Myeloid Leukemia+2 more
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 11
Large-scale testing (Phase 3)Not Yet RecruitingNCT07297914
What this trial is testing

Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Stem Cell TransplantGraft -Versus-host-disease
Bambino Gesù Hospital and Research Institute 1,000
Testing effectiveness (Phase 2)Study completedNCT01111526
What this trial is testing

Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Graft-Versus-Host Disease
H. Lee Moffitt Cancer Center and Research Institute 22
Testing effectiveness (Phase 2)Ended earlyNCT02379442
What this trial is testing

Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids

Who this might be right for
Graft-Versus-Host Disease
National Heart, Lung, and Blood Institute (NHLBI) 1
Testing effectiveness (Phase 2)Study completedNCT00061581
What this trial is testing

Experimental Bone Marrow Transplant Protocol

Who this might be right for
Acute Lymphocytic LeukemiaChronic Myeloid LeukemiaAcute Myelocytic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 14
Not applicableUnknownNCT05401955
What this trial is testing

Physiotherapy and Therapeutic Exercise Program in Graft-versus-host Disease (GvHD)

Who this might be right for
GVHD,AcuteGVHD, Chronic
University of Salamanca 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03924401
What this trial is testing

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant

Who this might be right for
Graft Versus Host Disease
Emory University 30
Not applicableUnknownNCT01699516
What this trial is testing

Non-invasive Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft-vs-Host Disease

Who this might be right for
Intestinal GVHDNeutropenic Enterocolitis
University of Pisa 32
Not applicableStudy completedNCT05216536
What this trial is testing

Physical and Cognitive Impairments in People Suffering From Long COVID

Who this might be right for
COVID-19SARS-CoV-2 InfectionCorona Virus Infection+6 more
Laval University 360
Very early researchLooking for participantsNCT04744116
What this trial is testing

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmSteroid Refractory Graft Versus Host Disease
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)WithdrawnNCT07349771
What this trial is testing

Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
Mayo Clinic
Early research (Phase 1)Study completedNCT03605927
What this trial is testing

CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease

Who this might be right for
Graft-versus-host-diseaseGVHDGVHD, Acute
H. Lee Moffitt Cancer Center and Research Institute 45
Large-scale testing (Phase 3)Ended earlyNCT02956122
What this trial is testing

GLASSIA for the Treatment of Acute GvHD

Who this might be right for
Graft Versus Host Disease
Baxalta now part of Shire 1
Not applicableLooking for participantsNCT07135583
What this trial is testing

Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury

Who this might be right for
Spinal Cord Injury, ChronicSpinal Cord Injury CervicalSpinal Cord Injury Thoracic+1 more
Thomas Jefferson University 20
Testing effectiveness (Phase 2)Study completedNCT00948727
What this trial is testing

Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantationGraft Versus Host Disease
Assistance Publique - Hôpitaux de Paris 39
Testing effectiveness (Phase 2)Ended earlyNCT00506948
What this trial is testing

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Who this might be right for
Hematological MalignanciesMyelodysplastic SyndromeLeukemia+1 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00089037
What this trial is testing

Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Next Page